FG-3246

Drug identity checked against registry records

Also recorded as FOR46

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)NCT06842498Kyntra BioPhase 2Recruiting2028-03-31Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.